State Street
BIOA

State Street’s BioAge Labs BIOA Stock Holding History

State Street’s Portfolio BIOA Stock Details BIOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$14.9M Buy
850,894
+428,048
+101% +$8.24M ﹤0.01% 2397
2025
Q4 		$5.59M Buy
422,846
+224,735
+113% +$1.99M ﹤0.01% 2944
2025
Q3 		$1.16M Buy
198,111
+37,262
+23% +$174K ﹤0.01% 3475
2025
Q2 		$664K Buy
160,849
+56,019
+53% +$226K ﹤0.01% 3565
2025
Q1 		$394K Buy
104,830
+57,421
+121% +$266K ﹤0.01% 3646
2024
Q4 		$274K Buy
+47,409
New +$817K ﹤0.01% 3777

Other funds holding BIOA

ACM
AH Capital Management Menlo Park, California $1.29B AUM 26.81% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

State Street's BIOA Position: Q1 2026 in Review

State Street increased its BioAge Labs (BIOA) stake by 101% in Q1 2026, buying an estimated $8.24M and bringing the position to 850,894 shares worth $14.9M. The position accounts for ﹤0.01% of the portfolio, ranked #2397.

State Street first reported a position in BIOA in Q4 2024 and has held it in 6 quarters since. 144 funds tracked by Wall St. Rank hold BIOA as of Q1 2026.

  • State Street held 850,894 shares of BioAge Labs worth $14.9M as of Q1 2026.
  • State Street bought 428,048 BioAge Labs shares in Q1 2026, an estimated $8.24M.
  • BioAge Labs made up ﹤0.01% of State Street's portfolio in Q1 2026, its #2397 holding.
  • State Street first reported a position in BioAge Labs in Q4 2024 and has held it in 6 quarters since.
  • 144 funds tracked by Wall St. Rank held BioAge Labs as of Q1 2026.

Based on State Street's 13F filing for Q1 2026, filed 15 May 2026.